The impact of COVID-19 on vulnerable cancer patient group is largely unknown, with only small cohorts of patients in early reports from China and Italy. We already know the large impact COVID-19 is having locally on cancer services, with staffing and resource issues, as well as the more measured approaches needed to anti-cancer therapy decisions in order to minimise the risk to patients at this difficult time. This national reporting project connects the UK's cancer centres to provide up-to-date information not only on the location of cases, but monitor for trends in morbidity and mortality associated with COVID-19.
This is the first time a coronavirus cancer emergency registry has been launched in the world.
Led by University of Birmingham and University of Oxford and is widely supported by the Association of Cancer Physicians, the Royal College of Radiologists, UK Chemotherapy Board, NOTCH (National Oncology Trainees Collaborative for Healthcare Research) and Cancer Research UK.
Leading for VCC:
Drs. Ashley Poon-king and Clair Brunner supported by Profs. Peter Barrett-Lee and John Chester .